Medicortex Finland Oyj
Medicortex Finland is dedicated to improving the diagnostics, treatment, and prevention of acute neurodegenerative conditions, with a current focus on developing a diagnostic kit for Traumatic Brain Injury (TBI). The company aims to create a rapid, reliable, and easy-to-use biomarker-based diagnostic test for TBI, which can be used at the point of injury or in routine medical checks, to ensure even mild cases are diagnosed and treated promptly.
Industries
Nr. of Employees
small (1-50)
Medicortex Finland Oyj
Products
Handheld biomarker-based rapid diagnostic kit for traumatic brain injury
A disposable, point-of-care diagnostic test format designed to detect TBI-associated biomarkers from non-invasive samples (saliva or urine) and provide a rapid visual yes/no result without laboratory equipment.
IndicateTBI
A rapid saliva-based test prototype for the detection of mild traumatic brain injury and concussions.
ProbTBI
A rapid urine-based lateral flow test prototype for the detection of mild traumatic brain injury (mTBI) using glycan biomarkers.
TesTBI
A second-generation electrochemical sensor and quantitative reading device utilizing synthetic aptamers for advanced biomarker detection.
Handheld biomarker-based rapid diagnostic kit for traumatic brain injury
A disposable, point-of-care diagnostic test format designed to detect TBI-associated biomarkers from non-invasive samples (saliva or urine) and provide a rapid visual yes/no result without laboratory equipment.
IndicateTBI
A rapid saliva-based test prototype for the detection of mild traumatic brain injury and concussions.
ProbTBI
A rapid urine-based lateral flow test prototype for the detection of mild traumatic brain injury (mTBI) using glycan biomarkers.
TesTBI
A second-generation electrochemical sensor and quantitative reading device utilizing synthetic aptamers for advanced biomarker detection.
Services
Collaborative research and development partnerships to co-develop biomarker assays and therapeutic candidates for traumatic brain injury; includes LOIs and partnership agreements.
Design and execution support for clinical validation studies of diagnostic assays intended to detect TBI, including study protocols and data collection for performance evaluation.
Collaborative research and development partnerships to co-develop biomarker assays and therapeutic candidates for traumatic brain injury; includes LOIs and partnership agreements.
Design and execution support for clinical validation studies of diagnostic assays intended to detect TBI, including study protocols and data collection for performance evaluation.
Expertise Areas
- TBI biomarker diagnostics
- Point-of-care rapid diagnostics
- Clinical validation and trial execution for diagnostics
- Preclinical therapeutic development for brain injury
Key Technologies
- Biomarker-based diagnostics
- Point-of-care rapid immunoassays / dipstick assays
- Non-invasive saliva and urine sampling
- Clinical diagnostic validation studies